Suspension of trading
Centessa Pharmaceuticals plc Stock
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
23:00:00 23/06/2026 +03
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.59B 5.21B 4.74B 8.93B 603B 8.99B 62.86B 24.45B 308B 23.53B 23.02B 989B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.43B 5.06B 4.61B 8.68B 587B 8.74B 61.09B 23.77B 299B 22.86B 22.37B 962B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 6 months | +2.04% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 17.05 | | 40.56 |
| 3 years | 5.33 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/24/26 A | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 5/1/26 A | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 3/26/26 A | Exercice | Executive/Senior Manager | 71,994 | 0.0539% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +74.34% | +588.78% | 6.27B | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -0.37% | -3.88% | +19.75% | +78.35% | 57.39B | |
| +1.63% | +0.98% | +3.83% | +38.21% | 47.64B | |
| +0.50% | +1.32% | +344.62% | +753.25% | 44.29B | |
| +3.05% | -1.58% | +28.78% | +35.46% | 42.5B | |
| +1.00% | +0.22% | +5.17% | +113.80% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | |
| +1.56% | +4.53% | +31.34% | +26.92% | 28.53B | |
| +0.76% | -0.89% | -7.44% | -11.43% | 24.34B | |
| Average | +1.26% | -0.34% | +55.91% | +177.16% | 39.68B | |
| Weighted average by Cap. | +1.53% | -0.80% | +58.32% | +147.82% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.37 12.46 11.35 21.38 1.44K 21.52 150.47 58.53 736.58 56.31 55.09 2.37K |
| Net income | -236M -210M -196M -178M -336M -22.7B -338M -2.36B -920M -11.58B -885M -866M -37.22B | -198M -176M -164M -149M -282M -19.02B -283M -1.98B -771M -9.7B -742M -725M -31.19B |
| Net Debt | -364M -325M -303M -276M -519M -35.09B -523M -3.65B -1.42B -17.89B -1.37B -1.34B -57.53B | -176M -157M -146M -133M -251M -16.97B -253M -1.77B -688M -8.65B -661M -647M -27.82B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
